Scientists find another key to HIV success

March 22, 2006

Weill Cornell Medical College scientists say they've determined a protein produced by HIV infected cells prevents immune B cells from producing antibodies.

The finding, say the researchers, could alter the way experts view HIV, helping to explain how the virus evades the immune system during the first days and weeks of infection.

It also helps unravel a paradox in HIV treatment: The fact that patients can have high blood levels of immune T cells and yet still be vulnerable to the virus.

"It's because the virus produces this protein, negative factor (Nef), which enters B cells to prevent antibodies being targeted to HIV," explained lead researcher Dr. Andrea Cerutti, an assistant professor of pathology and laboratory medicine. "This process leaves other, less targeted immune responses intact -- but since they pose little threat to the virus, HIV proliferates."

The findings appear in this month's issue of Nature Immunology.

Copyright 2006 by United Press International

Explore further: 'Shock and kill' strategy for curing HIV may endanger patients' brains

Related Stories

HIV expert's studies yielding insights into diseases of aging

November 30, 2016

While AIDS originally was seen as an adaptive immune disease, the research of Alan Landay, PhD, has contributed to a view of it as a cell driven-inflammation linked to immunosenescence—the gradual deterioration of the immune ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.